Scienture Holdings SCNX
NASDAQ SCNX
$0.37 +0.01 (+1.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scienture Holdings (SCNX) Non-Current Deferred Tax Liability (2024 - 2026)

Scienture Holdings' (SCNX) quarterly Non-Current Deferred Tax Liability came in at $11.0 million in Q2 2026, down 18.39% year-over-year from $13.5 million in Q2 2025, and little changed quarter-over-quarter from $11.0 million in Q1 2026.

Analysis

Scienture Holdings (SCNX) Non-Current Deferred Tax Liability (2024 - 2026) Analysis & Trends

Scienture Holdings has disclosed Non-Current Deferred Tax Liability across 3 years of filings, most recently posting $11.0 million for Q2 2026.

  • In Q2 2026, Non-Current Deferred Tax Liability fell 18.39% year-over-year to $11.0 million; the TTM figure through Jun 2026 stood at $11.0 million (down 18.39% YoY), while the FY2025 annual figure was $11.0 million, down 18.39% from the prior year.
  • Non-Current Deferred Tax Liability came in at $11.0 million for Q2 2026 at Scienture Holdings, roughly flat from $11.0 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $13.5 million in Q4 2024 to a low of $11.0 million in Q4 2025.
  • Average Non-Current Deferred Tax Liability over 3 years is $12.3 million, with a median of $12.3 million recorded in 2024.
  • The largest YoY upside for Non-Current Deferred Tax Liability was 18.39% in 2025 against a maximum downside of 18.39% in 2025.
  • Over 3 years, Non-Current Deferred Tax Liability stood at $13.5 million in 2024, then fell by 18.39% to $11.0 million in 2025, then changed by 0.0% to $11.0 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $11.0 million in Q2 2026, $11.0 million in Q1 2026, and $11.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn
10 Scienture Holdings 15.19 Mn 15.19 Mn 335,779.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.04 Mn
Mar 31, 2026 11.04 Mn
Dec 31, 2025 11.04 Mn
Jun 30, 2025 13.52 Mn
Mar 31, 2025 13.52 Mn
Dec 31, 2024 13.52 Mn